Over the last several months, PULSE and its network of nearly 40 partners have continued to build awareness of the unique and fundamental role of life sciences mergers and acquisitions (M&A). Read below for a round-up of recent PULSE updates and commentaries.
Advocating on Capitol Hill for the Critical Role of Life Sciences M&A
PULSE partners recently met with more than two dozen Congressional members and staff to discuss the importance of competition policies that recognize and support the role of life sciences M&A in helping companies of all sizes to bring new treatments and cures to market.
Eliminating Red Tape for Pro-Competitive Life Sciences M&A
PULSE weighed in on recent requests for information (RFIs) from the Department of Justice (DOJ)’s Anticompetitive Regulations Task Force and White House Office of Management and Budget (OMB). As PULSE’s comments note, eliminating barriers to pro-competitive life sciences M&A is critical to support America’s continued leadership in bringing new medical breakthroughs to patients.
- Read PULSE’s comments to DOJ’s Anticompetitive Regulations Task Force
- Read PULSE’s response to OMB’s RFI on Deregulation
Spotlighting Examples of Life Sciences “Innovations Advanced by M&A”
PULSE continues to feature real-world examples of medical breakthroughs brought to patients through a merger or acquisition across a variety of disease areas. Read more from PULSE’s “Innovations Advanced by M&A” content series:
- A Breakthrough Treatment for Myasthenia Gravis
- A First-in-Class Therapy for Chronic Graft-Versus-Host Disease
- A Novel Treatment for Atopic Dermatitis
Reinforcing the Unique and Fundamental Role of Life Sciences M&A
PULSE published a new suite of resources designed to educate on the unique competition dynamics and market realities in the life sciences industry, as well as recent policies that threaten to deter these crucial partnerships.
Highlighting the Importance of M&A to Sustain Investment, Innovation in America’s Life Sciences Ecosystem
Amid a challenging funding environment, PULSE continues to emphasize the vital role of M&A in helping life sciences companies secure investment to sustain innovation, scale up domestic manufacturing, and, ultimately, compete to bring new breakthroughs to market. Read more from PULSE’s blog:
- Axios: M&A a “Life Raft” for Investment, Innovation in America’s Life Sciences Industry
- Life Sciences M&A Fuels Domestic Manufacturing
- M&A Fuels Innovation and Competition in Obesity Treatment
To learn more about PULSE, visit our website at www.pulseforinnovation.org.